THC Therapeutics Inc

(THCT)

By |

A NEW KIND OF CANNABIS COMPANY

THC Therapeutics, inc. is a forward-thinking publicly traded company in the cannabis industry focusing on health and healing. The company is developing their patent-pending product the dHydronator®, a sanitizing herb dryer. The main function of the dHydronator is to greatly accelerate drying time while sanitizing Cannabis. The dHydronator is proven to reduce the drying time from 10-14 days to less than 14 hours. The company is currently generating revenue from its brand of float spas. THC Therapeutics will be getting involved in testing facilities, cultivation of Cannabis and personal wellness centers. The Company is seeking partnerships, mergers and acquisitions in the cannabis, health and healing industries.

LEGAL CANNABIS IS THE FASTEST GROWING INDUSTRY IN THE UNITED STATES

dHydronator®

INTRODUCING A NEW INDUSTRY STANDARD IN DRYING AND SANITIZING

The main function of the dHydronator® is to reduce moisture and effectively dry out plant matter in a short period of time when compared to traditional methods which can take weeks or months. We have developed a product that can achieve an industry recognized relative humidity standard in less than 14 hours. We have a working prototype that has been tested and is proven to achieve a drying criteria of 8-15% moisture. The dHydronator has also been proven effective in eliminating the presence and viability of contaminants on any plant matter or objects placed into the dryer such as glass pipes and smoking accessories. Current quick-dry methods utilize crude appliances such as conventional ovens and microwaves which significantly damage the plant matter on a macro and molecular level.

We have done extensive research to develop a technology that accelerates drying time without the plant material being damaged and without the complications that other methods present. Simply place your freshly harvested cannabis and all other herbs in the dHydronator, turn it on and in 12-14 hours your herbs will be dried to industry humidity standards. We believe that applications for this product in the cannabis industry are widespread and can accommodate the needs of cultivators, dispensaries and cannabis consumers. The patent pending dHydronator technology is fully scalable and could be made to accommodate a wide range of quantities and processes. We have a working prototype that has been tested, and prior to commercial release we intend to upgrade the technology and visual components to meet marketplace demand.

LABORATORY PROVEN TECHNOLOGY

Over the past two years we have created two generations of the dHydronator® with built-in SanitiZen® technology which have been subjected to rigorous independent laboratory testing. The first generation prototype dHydronator was subjected to a full battery of tests by an independent laboratory based in Colorado. The results were spectacular, they confirmed we had something revolutionary for the cannabis, herb and agriculture industries. All tests were repeated with 5 different replicates to provide enough data points for statistical analysis and to ensure accuracy. View the report for the first generation dHydronator here.

This chart , from DigiPathLabs preliminary report, demonstrates the moisture and total aerobic count reduction over time. Total Aerobic Count (TAC) represents an indicator of microbial populations on the cannabis samples. TAC was reduced dramatically from 300,000 to 78,000 over 15.5 hours. Moisture content was reduced from 80% down to 8.4% after 14 hours. Nevada’s drying criteria is from 8 to 15% moisture content. Cured data point is from the same strain and for reference purposes only. View the report for the second generation dHydronator here. Report is censored to protect proprietary information.

MANAGEMENT

BRANDON ROMANEK
FOUNDER & CEO

Brandon has over 20 years of experience managing a healthcare business and over 15 years experience of money management, trading/investing of stocks, options and commodities. A significant part of Brandon’s net worth is held in physical Gold and Silver. He was a broker/dealer in the precious metals market. Brandon has led the formation of THC Therapeutics to become a publicly traded company. Brandon states THC Therapeutics is a real company with proven technology. We have an experienced management team to ramp up sales for our proprietary new market category technologies. He is passionate about growing our company in the legal cannabis industry.

Brandon manages the department directors, budgets, financing, hiring and devise strategies for growth and expansion. He will seek mergers and acquisitions of cannabis and related holistic care businesses. Monitor and grow portfolio of assets that enhance our business, and act as the liaison with investors, public relations and compliance with any government regulations.


JOSHUA HALFORD
CHIEF TECHNOLOGY OFFICER

Joshua is responsible for product design and product development, company brand strategy, social media presence, web presence, advertising campaign development, media relations and company information technologies. He has an extensive technology background and has experience in many different fields including information technology, technical and structural diagnosis and repair, creative marketing, graphic design, video production, print media, website development, plant compound extraction and wellness center management.

In addition to technology and design, Joshua has over 5 years of experience in terpene extraction, and has spent recent months delving into CO2, C4H10 and C3H8 extraction. Prior to joining THC Therapeutics, Joshua was the owner and operator of Roundbox Studio which was responsible for the grassroots branding and development of dozens of companies and consumer products including CBD infused edibles.

Joshua has been involved as a brand strategy consultant in the cannabis industry for name-brand products companys and organizations. Joshua’s background in laboratory extraction processes has made him an excellent resource for company research and development in exploring new product concepts.


DR. JOHN PIERCE
MEDICAL DIRECTOR

Dr. John J. Pierce is the Medical Director of Ageless Forever. He is Board Certified in Emergency Medicine and is also Board Certified by the Anti-Aging and Regenerative Medicine. He received his medical training from Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, located in Pomona California. He also has a Bachelor of Science degree in Kinesiology from the University of Nevada, Las Vegas. Dr. Pierce is an exercise enthusiast and has a lifetime of involvement as a competitive athlete, with special focus in weight training and nutrition. He also serves as a Tactical Physician with the Las Vegas SWAT team.

Dr. Pierce has been practicing medicine for almost 15 years, he has tremendous experience in the wellness industry ranging from nutritional supplements, herbs, Vitamin IV, anti-aging and is a foremost expert in hormone replacement therapy. Unlike many doctors, Pierce looks at medicine from a holistic standpoint. He understands that pharmaceuticals have their place in medicine, but agrees with THC Therapeutics that many issues can be solved with proper diet, nutrition, exercise and specialized therapies.


KATHRYN MOROZ
SPA DEVELOPMENT CONSULTANT

Spa Advisors, Inc. founder, Kathryn Moroz, has been in the spa and salon industry for nearly two decades. Having begun her career in retail buying over twenty years ago, Kathryn joined the spa and salon industry as Vice President of Merchandising and Training for Elizabeth Arden Red Door Salons, Inc. Her early expertise in product procurement, vendor negotiations, technical training programs, visual merchandising, and promotional strategies led the Red Door Salons to national acclaim. After her success with Elizabeth Arden, Kathryn launched Spa Advisors, Inc., primarily out of the urging of several business colleagues in need of her expertise.

ADDITIONAL INFORMATION


In the interest of full disclosure, we call the reader's attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

THC Therapeutics Inc

Profile

THC Therapeutics is a forward-thinking publicly traded health and healing company in the cannabis industry that has “Better Health through the Science of Nature” as their mission statement. The company is dedicated to innovating new methods and refining current industry standards in the cannabis market. THC Therapeutics plans for future growth include cultivation, dispensing, extractions, edibles, personal wellness centers and flotation therapy. For more information, visit THCTherapeutics.com.

Contact Information

Website: www.thctherapeutics.com
Main Phone: +1 702 602-8422
Address: 11700 W Charleston Boulevard
Address 2: Suite 73
State: NV
City / Town: Las Vegas
Country: USA
Postal Code: 89135

Issuer Information

Exchange: OTO
CEO: Brandon Romanek
Issuer Type: CS - Common Stock
Sector/Industry: Healthcare
NAICS: Ophthalmic Goods
$ 0.36 $ -0.0375 (-9.43%)
Last Price 0.36 Change $ -0.0375 Change % -9.43 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.38 High 0.38 Low 0.33 Prev Close 0.40
Last Trade Volume 8,366 52 Wk Hi 1.30 52 Wk Low 0.02
Market Cap 1.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 5,288,376.00 EPS (TTM) -0.01 PE Ratio N/A Exchange OTCPK